nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Peritonitis—Vandetanib—thyroid cancer	0.108	0.108	CcSEcCtD
Lincomycin—Cardio-respiratory arrest—Vandetanib—thyroid cancer	0.0762	0.0762	CcSEcCtD
Lincomycin—Proteinuria—Vandetanib—thyroid cancer	0.031	0.031	CcSEcCtD
Lincomycin—Protein urine present—Vandetanib—thyroid cancer	0.0306	0.0306	CcSEcCtD
Lincomycin—Colitis—Vandetanib—thyroid cancer	0.0261	0.0261	CcSEcCtD
Lincomycin—Proteinuria—Sorafenib—thyroid cancer	0.0209	0.0209	CcSEcCtD
Lincomycin—Dermatitis bullous—Vandetanib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Lincomycin—Protein urine present—Sorafenib—thyroid cancer	0.0206	0.0206	CcSEcCtD
Lincomycin—Glossitis—Sorafenib—thyroid cancer	0.0199	0.0199	CcSEcCtD
Lincomycin—Neutropenia—Vandetanib—thyroid cancer	0.016	0.016	CcSEcCtD
Lincomycin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0153	0.0153	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0151	0.0151	CcSEcCtD
Lincomycin—Stomatitis—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Lincomycin—Erythema multiforme—Vandetanib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Lincomycin—Anorectal discomfort—Epirubicin—thyroid cancer	0.0124	0.0124	CcSEcCtD
Lincomycin—Local reaction—Epirubicin—thyroid cancer	0.0123	0.0123	CcSEcCtD
Lincomycin—Vesiculobullous rash—Epirubicin—thyroid cancer	0.0121	0.0121	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—thyroid cancer	0.0115	0.0115	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—thyroid cancer	0.0113	0.0113	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—thyroid cancer	0.0112	0.0112	CcSEcCtD
Lincomycin—Abdominal discomfort—Sorafenib—thyroid cancer	0.011	0.011	CcSEcCtD
Lincomycin—Neutropenia—Sorafenib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Lincomycin—Stomatitis—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Lincomycin—Jaundice—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Lincomycin—Erythema multiforme—Sorafenib—thyroid cancer	0.00872	0.00872	CcSEcCtD
Lincomycin—Tinnitus—Sorafenib—thyroid cancer	0.0086	0.0086	CcSEcCtD
Lincomycin—Abscess—Epirubicin—thyroid cancer	0.00858	0.00858	CcSEcCtD
Lincomycin—Rash pustular—Epirubicin—thyroid cancer	0.00851	0.00851	CcSEcCtD
Lincomycin—Pain—Vandetanib—thyroid cancer	0.00831	0.00831	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—thyroid cancer	0.00794	0.00794	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—thyroid cancer	0.00788	0.00788	CcSEcCtD
Lincomycin—Abdominal pain—Vandetanib—thyroid cancer	0.00768	0.00768	CcSEcCtD
Lincomycin—Body temperature increased—Vandetanib—thyroid cancer	0.00768	0.00768	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—thyroid cancer	0.00737	0.00737	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—thyroid cancer	0.00737	0.00737	CcSEcCtD
Lincomycin—Angioedema—Sorafenib—thyroid cancer	0.00734	0.00734	CcSEcCtD
Lincomycin—Leukopenia—Sorafenib—thyroid cancer	0.00719	0.00719	CcSEcCtD
Lincomycin—Pruritus—Vandetanib—thyroid cancer	0.00687	0.00687	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—thyroid cancer	0.00682	0.00682	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—thyroid cancer	0.00682	0.00682	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Lincomycin—Diarrhoea—Vandetanib—thyroid cancer	0.00665	0.00665	CcSEcCtD
Lincomycin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00655	0.00655	CcSEcCtD
Lincomycin—Colitis—Epirubicin—thyroid cancer	0.00652	0.00652	CcSEcCtD
Lincomycin—Shock—Sorafenib—thyroid cancer	0.00645	0.00645	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—thyroid cancer	0.00641	0.00641	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—thyroid cancer	0.00637	0.00637	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00628	0.00628	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—thyroid cancer	0.0062	0.0062	CcSEcCtD
Lincomycin—Vomiting—Vandetanib—thyroid cancer	0.00618	0.00618	CcSEcCtD
Lincomycin—Rash—Vandetanib—thyroid cancer	0.00613	0.00613	CcSEcCtD
Lincomycin—Dermatitis—Vandetanib—thyroid cancer	0.00612	0.00612	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—thyroid cancer	0.00603	0.00603	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—thyroid cancer	0.00593	0.00593	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—thyroid cancer	0.0059	0.0059	CcSEcCtD
Lincomycin—Nausea—Vandetanib—thyroid cancer	0.00577	0.00577	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—thyroid cancer	0.00574	0.00574	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—thyroid cancer	0.00572	0.00572	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—thyroid cancer	0.00569	0.00569	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00564	0.00564	CcSEcCtD
Lincomycin—Pain—Sorafenib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—thyroid cancer	0.00529	0.00529	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00527	0.00527	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00522	0.00522	CcSEcCtD
Lincomycin—Urticaria—Sorafenib—thyroid cancer	0.00521	0.00521	CcSEcCtD
Lincomycin—Abdominal pain—Sorafenib—thyroid cancer	0.00518	0.00518	CcSEcCtD
Lincomycin—Body temperature increased—Sorafenib—thyroid cancer	0.00518	0.00518	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—thyroid cancer	0.00516	0.00516	CcSEcCtD
Lincomycin—Hypersensitivity—Sorafenib—thyroid cancer	0.00483	0.00483	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Lincomycin—Pruritus—Sorafenib—thyroid cancer	0.00464	0.00464	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—thyroid cancer	0.00455	0.00455	CcSEcCtD
Lincomycin—Diarrhoea—Sorafenib—thyroid cancer	0.00448	0.00448	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00421	0.00421	CcSEcCtD
Lincomycin—Vomiting—Sorafenib—thyroid cancer	0.00417	0.00417	CcSEcCtD
Lincomycin—Rash—Sorafenib—thyroid cancer	0.00413	0.00413	CcSEcCtD
Lincomycin—Dermatitis—Sorafenib—thyroid cancer	0.00413	0.00413	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—thyroid cancer	0.00398	0.00398	CcSEcCtD
Lincomycin—Nausea—Sorafenib—thyroid cancer	0.00389	0.00389	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00376	0.00376	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—thyroid cancer	0.00369	0.00369	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—thyroid cancer	0.00318	0.00318	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—thyroid cancer	0.00294	0.00294	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Lincomycin—Shock—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Lincomycin—Shock—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Lincomycin—Pain—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Lincomycin—Pain—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Lincomycin—Rash—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Lincomycin—Nausea—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Lincomycin—Rash—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
